Cancer evolution: Mathematical models and computational inference

Systematic Biology

Volumn 64, Issue 1, 2015, Pages e1-e25

  Beerenwinkel, Niko ^a,b   Schwarz, Roland F ^c   Gerstung, Moritz ^d   Markowetz, Florian ^e  

^a ETH ZURICH   (Switzerland)

^b SWISS INSTITUTE OF BIOINFORMATICS   (Switzerland)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^d WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MODEL; EVOLUTION; HUMAN; MUTATION; NEOPLASM; PHYLOGENY;

BIOLOGICAL EVOLUTION; HUMANS; MODELS, BIOLOGICAL; MUTATION; NEOPLASMS; PHYLOGENY;

EID: 84965147607     PISSN: 10635157     EISSN: 1076836X     Source Type: Journal    
DOI: 10.1093/sysbio/syu081     Document Type: Article

References (235)

1. Adams R. P., Ghahramani Z., Jordan M. I. 2010. Tree-structured stick breaking processes for hierarchical data. Adv. Neural Inf. Process. Syst. (NIPS). 23:19-27.
2. Adey A., Burton J. N., Kitzman J. O., Hiatt J. B., Lewis A. P., Martin B. K., Qiu R., Lee C., Shendure J. 2013. The haplotype-resolved genome and epigenome of the aneuploid HeLa cancer cell line. Nature 500:207-211.
3. Adzhubei I. A., Schmidt S., Peshkin L., Ramensky V. E., Gerasimova A., Bork P., Kondrashov A. S., Sunyaev S. R. 2010. A method and server forpredicting damaging missense mutations. Nat. Methods 7:248-249.
4. Aktipis C. A., Kwan V. S. Y., Johnson K. A., Neuberg S. L., Maley C. C. 2011. Overlooking evolution: a systematic analysis of cancer relapse and therapeutic resistance research. PLoS ONE 6:e26100.
5. Alarcón T., Byrne H., Maini P. 2005. A multiple scale model for tumor growth. Multiscale Model. Simul. 3:440-475.
6. Albini A., Sporn M. B. 2007. The tumour microenvironment as a target for chemoprevention. Nat. Rev. Cancer 7:139-147.
7. Almendro V., Cheng Y.-K., Randles A., Itzkovitz S., Marusyk A., Ametller E., Gonzalez-Farre, X., Munoz M., Russnes H. G., Helland A., Rye I. H., Borresen-Dale A.-L., Maruyama R., Van Oudenaarden A., Dowsett M., Jones R. L., Reis-Filho J., Gascon P., Goenen M., Michor F., Polyak K. 2014. Inference of tumor evolution during chemotherapy by computational modeling and in situ analysis of genetic and phenotypic cellular diversity. Cell Rep. 6:514-527.
8. Almendro V., Marusyk A., Polyak K. 2013. Cellular heterogeneity and molecular evolution in cancer. Annu. Rev. Pathol. 8:277-302.
9. Amir E.-A. D., Davis K. L., Tadmor M. D., Simonds E. F., Levine J. H., Bendall S. C., Shenfeld D. K., Krishnaswamy S., Nolan G. P., Pe'er D. 2013. viSNE enables visualization of high dimensional singlecell data and reveals phenotypic heterogeneity of leukemia. Nat. Biotechnol. 31:545-552.
10. Anderson A. R. A., Quaranta V. 2008. Integrative mathematical oncology. Nat. Rev. Cancer 8:227-234.
11. Aparicio S., Caldas C. 2013. The implications of clonal genome evolution for cancer medicine. N. Engl. J. Med. 368:842-851.
12. Armitage P., Doll R. 1954. The age distribution of cancer and a multistage theory of carcinogenesis. Br. J. Cancer 8:1-12.
13. Armitage P., Doll R. 1957. A two-stage theory of carcinogenesis in relation to the age distribution of human cancer. Br. J. Cancer 11:161-169.
14. Athreya K, Ney P. 1972. Branching processes. Mineola (NY): Dover.
15. Attolini C. S.-O., Cheng Y. K., Beroukhim R., Getz G., Abdel-Wahab O., Levine R. L., Mellinghoff I. K., Michor F. 2010. A mathematical framework to determine the temporal sequence of somatic genetic events in cancer. Proc. Natl. Acad. Sci. USA 107:17604-17609.
16. Axelrod R., Axelrod D. E., Pienta K. J. 2006. Evolution of cooperation among tumor cells. Proc. Natl. Acad. Sci. USA 103:13474-13479.
17. Axelrod R., Hamilton W. D. 1981. The evolution of cooperation. Science 211:1390-1396.
18. Baca S. C., Prandi D., Lawrence M. S., Mosquera J. M., Romanel A., Drier Y., Park K., Kitabayashi N., MacDonald T. Y., Ghandi M., Van Allen E., Kryukov G. V., Sboner A., Theurillat J.-P., Soong T. D., Nickerson E., Auclair D., Tewari A., Beltran H., Onofrio R. C., Boysen G., Guiducci C., Barbieri C. E., Cibulskis K., Sivachenko A., Carter S. L., Saksena G., Voet D., Ramos A. H., Winckler W., Cipicchio M., Ardlie K., Kantoff P. W., Berger M. F., Gabriel S. B., Golub T. R., Meyerson M., Lander E. S., Elemento O., Getz G., Demichelis F., Rubin M. A., Garraway L. A. 2013. Punctuated evolution of prostate cancer genomes. Cell 153:666-677.
19. Barcellos-Hoff M. H., Lyden D., Wang T. C. 2013. The evolution of the cancer niche during multistage carcinogenesis. Nat. Rev. Cancer 13:511-518.
20. Basanta D., Scott J. G., Fishman M. N., Ayala G., Hayward S. W., Anderson A. R. A. 2012. Investigating prostate cancer tumour-stroma interactions: Clinical and biological insights from an evolutionary game. Br. J. Cancer 106:174-181.
21. Basik M., Aguilar-Mahecha A., Rousseau C., Diaz Z., Tejpar S., Spatz A., Greenwood C. M. T., Batist G. 2013. Biopsies: Next-generation biospecimens for tailoring therapy. Nat. Rev. Clin. Oncol. 10:437-450.
22. Bedard P. L., Hansen A. R., Ratain M. J., Siu L. L. 2013. Tumour heterogeneity in the clinic. Nature 501:355-364.
23. Beerenwinkel N., Antal T., Dingli D., Traulsen A., Kinzler K. W., Velculescu V. E., Vogelstein B., Nowak M. A. 2007a. Genetic progression and the waiting time to cancer. PLoS Comput. Biol. 3:e225.
24. Beerenwinkel N., Eriksson N., Sturmfels B. 2006. Evolution on distributive lattices. J. Theor. Biol. 242:409-420.
25. Beerenwinkel N., Eriksson N., Sturmfels B. 2007b. Conjunctive Bayesian networks. Bernoulli. 13:893-909.
26. Beerenwinkel N., Rahnenführer J., Däumer M., Hoffmann D., Kaiser R., Selbig J., Lengauer T. 2005a. Learning multiple evolutionary pathways from cross-sectional data. J. Comput. Biol. 12:584-598.
27. Beerenwinkel N., Rahnenführer J., Kaiser R., Hoffmann D., Selbig J., Lengauer T. 2005b. Mtreemix: a software package for learning and using mixture models of mutagenetic trees. Bioinformatics 21:2106-2107.
28. Beerenwinkel N., Sullivant S. 2009. Markov models for accumulating mutations. Biometrika 96:645-661.
29. Bissell M. J., Hines W. C. 2011. Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nat. Med. 17:320-329.
30. Bowtell D. D. L. 2010. The genesis and evolution of high-grade serous ovarian cancer. Nat. Rev. Cancer 10:803-808.
31. Bozic I., Allen B., Nowak M. A. 2012. Dynamics of targeted cancer therapy. Trends Mol. Med. 18:311-316.
32. Bozic I., Antal T., Ohtsuki H., Carter H., Kim D., Chen S., Karchin R., Kinzler K. W., Vogelstein B., Nowak M. A. 2010. Accumulation of driver and passenger mutations during tumor progression. Proc. Natl. Acad. Sci. USA 107:18545-18550.
33. Bozic I., Reiter J. G., Allen B., Antal T., Chatterjee K., Shah P., Moon Y. S., Yaqubie A., Kelly N., Le D. T., Lipson E. J., Chapman P. B., Diaz Jr, L. A., Vogelstein B., Nowak M. A. 2013. Evolutionary dynamics of cancer in response to targeted combination therapy. Elife 2:e00747.
34. Brumer Y., Michor F., Shakhnovich E. I. 2006. Genetic instability and the quasispecies model. J. Theor. Biol. 241:216-222.
35. Burrell R. A., McGranahan N., Bartek J., Swanton C. 2013. The causes and consequences of genetic heterogeneity in cancer evolution. Nature 501:338-345.
36. Cairns J. 1975. Mutation selection and the natural history of cancer. Nature 255:197-200.
37. Calabrese P., Tavaré S., Shibata D. 2004. Pretumor progression: Clonal evolution of human stem cell populations. Am. J. Pathol. 164:1337-1346.
38. Caldas C. 2012. Cancer sequencing unravels clonal evolution. Nat. Biotechnol. 30:408-410.
39. Campbell P. J., Yachida S., Mudie L. J., Stephens P. J., Pleasance E. D., Stebbings L. A., Morsberger L. A., Latimer C., McLaren S., Lin M.-L., McBride D. J., Varela I., Nik-Zainal S. A., Leroy C., Jia M., Menzies A., Butler A. P., Teague J. W., Griffin C. A., Burton J., Swerdlow H., Quail M. A., Stratton M. R., Iacobuzio-Donahue C., Futreal P. A. 2010. The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature 467:1109-1113.
40. Carlson C. A., Kas A., Kirkwood R., Hays L. E., Preston B. D., Salipante S. J., Horwitz M. S. 2012. Decoding cell lineage from acquired mutations using arbitrary deep sequencing. Nat. Methods. 9:78-80.
41. Carter S. L., Cibulskis K., Helman E., McKenna A., Shen H., Zack T., Laird P. W., Onofrio R. C., Winckler W., Weir B. A., Beroukhim R., Pellman D., Levine D. A., Lander E. S., Meyerson M., Getz G. 2012. Absolute quantification of somatic DNA alterations in human cancer. Nat. Biotechnol. 30:413-421.
42. Cheng Y. K., Beroukhim R., Levine R. L., Mellinghoff I. K., Holland E. C., Michor F. 2012. A mathematical methodology for determining the temporal order of pathway alterations arising during gliomagenesis. PLoS Comput. Biol. 8:e1002337.
43. Chmielecki J., Foo J., Oxnard G. R., Hutchinson K., Ohashi K., Somwar R., Wang L., Amato K. R., Arcila M., Sos M. L., Socci N. D., Viale A., De Stanchina E., Ginsberg M. S., Thomas R. K., Kris M. G., Inoue A., Ladanyi M., Miller V. A., Michor F., Pao W. 2011. Optimization of dosing for EGFR-mutant non-small cell lung cancer with evolutionary cancer modeling. Sci. Transl. Med. 3:90ra59.
44. Chowdhury S. A., Shackney S. E., Heselmeyer-Haddad K., Ried T., Schäffer A. A., Schwartz R. 2013. Phylogenetic analysisof multiprobe fluorescence in situ hybridization data from tumor cell populations. Bioinformatics 29:i189-i198.
45. Cibulskis K., Lawrence M. S., Carter S. L., Sivachenko A., Jaffe D., Sougnez C., Gabriel S., Meyerson M., Lander E. S., Getz G. 2013. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat. Biotechnol. 31:213-219.
46. Cooke S. L., Temple J., Macarthur S., Zahra M. A., Tan L. T., Crawford R. A. F., Ng C. K. Y., Jimenez-Linan M., Sala E., Brenton J. D. 2011. Intra-tumour genetic heterogeneity and poor chemoradiotherapy response in cervical cancer. Br. J. Cancer 104:361-368.
47. Cortes C., Haffner P., Mohri M. 2004. Rational Kernels: Theory and Algorithms. J. Mach. Lern. Res. 1:1-50.
48. Curtis C., Shah S. P., Chin S.-F., Turashvili G., Rueda O. M., Dunning M. J., Speed D., Lynch A. G., Samarajiwa S., Yuan Y., Gräf S., Ha G., Haffari G., Bashashati A., Russell R., McKinney S., M. E. T. A. B. R. I. C. G., Langerod A., Green A., Provenzano E., Wishart G., Pinder S., Watson P., Markowetz F., Murphy L., Ellis I., Purushotham A., Borresen-Dale A.-L., Brenton J. D., Tavaré S., Caldas C., Aparicio S. 2012. The genomic and transcriptomic architecture of 2, 000 breast tumours reveals novel subgroups. Nature 486:346-352.
49. Danesh K., Durrett R., Havrilesky L. J., Myers E. 2012. A branching process model of ovarian cancer. J. Theor. Biol. 314:10-15.
50. Datta R. S., Gutteridge A., Swanton C., Maley C. C., Graham T. A. 2013. Modelling the evolution of genetic instability during tumour progression. Evol. Appl. 6:20-33.
51. Dawson S.-J., Tsui D. W. Y., Murtaza M., Biggs H., Rueda O. M., Chin S.-F., Dunning M. J., Gale D., Forshew T., Mahler-Araujo B., Rajan S., Humphray S., Becq J., Halsall D., Wallis M., Bentley D., Caldas C., Rosenfeld N. 2013. Analysis of circulating tumor DNA to monitor metastatic breast cancer. N. Engl. J. Med. 368:1199-1209.
52. De Bruin E. C., Taylor T. B., Swanton C. 2013. Intra-tumor heterogeneity: lessons from microbial evolution and clinical implications. Genome Med. 5:101.
53. Desper R., Jiang F., Kallioniemi O. P., Moch H., Papadimitriou C. H., Schäffer A. A. 1999. Inferring tree models for oncogenesis from comparative genome hybridization data. J. Comput. Biol. 6:37-51.
54. Desper R., Jiang F., Kallioniemi O. P., Moch H., Papadimitriou C. H., Schaffer A. A. 2000. Distance-based reconstruction of tree models for oncogenesis. J. Comput. Biol. 7:789-803.
55. Deutsch A., Moreira J. 2002. Cellular automaton models of tumor development: A critical review. Ad. Complex Syst. 05:247-267.
56. Dewanji A., Jeon J., Meza R., Luebeck E. G. 2011. Number and size distribution of colorectal adenomas under the multistage clonal expansion model of cancer. PLoS Comput. Biol. 7:e1002213.
57. Dexter D. L., Kowalski H. M., Blazar B. A., Fligiel Z., Vogel R., Heppner G. H. 1978. Heterogeneity of tumor cells from a single mouse mammary tumor. Cancer Res. 38:3174-3181.
58. Diaz Jr L. A., Williams R. T, Wu J., Kinde I., Hecht J. R., Berlin J., Allen B., Bozic I., Reiter J. G., Nowak M. A., Kinzler K. W., Oliner K. S., Vogelstein B. 2012. The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers. Nature 468:973-977.
59. Dingli D., Chalub F. A. C. C., Santos F. C., Van Segbroeck S., Pacheco J. M. 2009. Cancer phenotype as the outcome of an evolutionary game between normal and malignant cells. Br. J. Cancer 101:1130-1136.
60. Dormann S., Deutsch A. 2002. Modeling of self-organized avascular tumor growth with a hybrid cellular automaton. In Silico Biol. 2:393-406.
61. Durrett R. 2002. Probability models for DNA sequence evolution. New York (NY): Springer.
62. Durrett R., Foo J., Leder K., Mayberry J., Michor F. 2010. Evolutionary dynamics of tumor progression with random fitness values. Theor. Popul. Biol. 78:54-66.
63. Durrett R., Foo J., Leder K., Mayberry J., Michor F. 2011. Intratumor heterogeneity in evolutionary models of tumor progression. Genetics. 188:461-477.
64. Durrett R., Mayberry J. 2011. Traveling waves of selective sweeps. Ann. Appl. Probab. 21:699-744.
65. Durrett R., Moseley S. 2010. Evolution of resistance and progression to disease during clonal expansion of cancer. Theor. Popul. Biol. 77:42-48.
66. Durrett R., Schmidt D., Schweinsberg J. 2009. A waiting time problem arising from the study of multi-stage carcinogenesis. Ann. Appl. Probab. 19:676-718.
67. Edmonds J. 1967. Optimum branchings. J. Res. Nat. Bur. Stand. 71B: 233-240.
68. Emmert-Buck M. R., Bonner R. F., Smith P. D., Chuaqui R. F., Zhuang Z., Goldstein S. R., Weiss R. A., Liotta L. A. 1996. Laser capture microdissection. Science 274:998-1001.
69. Ewens W. J. 2004. Mathematical population genetics, 2nd ed. (Interdisciplinary Applied Mathematics); Vol. 27. New York (NY): Springer.
70. Fearon E. R., Vogelstein B. 1990. A genetic model for colorectal tumorigenesis. Cell 61:759-767.
71. Feller W. 1951. Diffusion processes in genetics. In: Neyman P, ed., Proceedings of the Second Berkeley Symposium on Mathematical Statistics and Probability. Berkeley and Los Angeles (CA): University of California Press, pp. 227-246.
72. Felsenstein J. 2003. Inferring phylogenies. Sunderland (MA): Sinauer Associates.
73. Fidler I. J. 1978. Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Res. 38:2651-2660.
74. Fischer A., Vzquez-Garca I., Illingworth C. J. R., Mustonen V. 2014. Highdefinition reconstruction of clonal composition in cancer. Cell Rep. 7:1740-1752.
75. Fisher R. A. 1922. Onthe dominance ratio. P. Roy. Soc. Edinb. 42:321-341.
76. Fisher R. A. 1930. The genetical theory of natural selection. Oxford (UK): Oxford University Press.
77. Forshew T., Murtaza M., Parkinson C., Gale D., Tsui D. W. Y., Kaper F., Dawson S.-J., Piskorz A. M., Jimenez-Linan M., Bentley D., Hadfield J., May A. P., Caldas C., Brenton J. D., Rosenfeld N. 2012. Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA. Sci. Transl. Med. 4:136ra68.
78. Frank S. A. 2007. Dynamics of Cancer: Incidence, Inheritance, and Evolution. Princeton (NJ): Princeton University Press.
79. Frank S. A., Rosner M. R. 2012. Nonheritable cellular variability accelerates the evolutionary processes of cancer. PLoS Biol. 10:e1001296.
80. Frumkin D., Wasserstrom A., Itzkovitz S., Stern T., Harmelin A., Eilam R., Rechavi G., Shapiro E. 2008. Cell lineage analysis of a mouse tumor. Cancer Res. 68:5924-5931.
81. Fudenberg D., Nowak M. A., Taylor C., Imhof L. A. 2006. Evolutionary game dynamics infinite populations with strongselectionand weak mutation. Theor. Popul. Biol. 70:352-363.
82. Garraway L. A., Jänne P. A. 2012. Circumventing cancer drug resistance in the era of personalized medicine. Cancer Discov. 2:214-226.
83. Garraway L. A., Lander E. S. 2013. Lessons from the cancer genome. Cell 153:17-37.
84. Gatenby R. A., Vincent T. L. 2003. An evolutionary model of carcinogenesis. Cancer Res. 63:6212-6220.
85. Gerlinger M., Rowan A. J., Horswell S., Larkin J., Endesfelder D., Gronroos E., Martinez P., Matthews N., Stewart A., Tarpey P., Varela I., Phillimore B., Begum S., McDonald N. Q., Butler A., Jones D., Raine K., Latimer C., Santos C. R., Nohadani M., Eklund A. C., Spencer-Dene B., Clark G., Pickering L., Stamp G., Gore M., Szallasi Z., Downward J., Futreal P. A., Swanton C. 2012. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 366:883-892.
86. Gerstung M., Baudis M., Moch H., Beerenwinkel N. 2009. Quantifying cancer progression with conjunctive Bayesian networks. Bioinformatics 25:2809-2815.
87. Gerstung M., Beerenwinkel N. 2010. Waiting time models of cancer progression. Math. Pop. Stud. 17:115-135.
88. Gerstung M., Beisel C., Rechsteiner M., Wild P., Schraml P., Moch H., Beerenwinkel N. 2012. Reliable detection of subclonal singlenucleotide variants in tumour cell populations. Nat. Commun. 3:811.
89. Gerstung M., Eriksson N., Lin J., Vogelstein B., Beerenwinkel N. 2011a. The temporal order of genetic and pathway alterations in tumorigenesis. PLoS ONE 6:e27136.
90. Gerstung M., Nakhoul H., Beerenwinkel N. 2011b. Evolutionary games with affine fitness functions: Applications to cancer. Dynamic Games and Applications 1:370-385.
91. Goldie J. H., Coldman A. J. 1979. A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat. Rep. 63:1727-1733.
92. Gonzalez-Perez A., Perez-Llamas C., Deu-Pons J., Tamborero D., Schroeder M. P., Jene-Sanz A., Santos A., Lopez-Bigas N. 2013. Intogen-mutations identifies cancer drivers across tumor types. Nat. Methods 10:1081-1082.
93. Gould S. J., Eldredge N. 1993. Punctuated equilibrium comes of age. Nature 366:223-227.
94. Greaves M., Maley C. C. 2012. Clonal evolution in cancer. Nature 481:306-313.
95. Greenman C., Stephens P., Smith R., Dalgliesh G. L., Hunter C., Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S., Vastrik I., Schmidt E. E., Avis T., Barthorpe S., Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A., Cahill D. P., Louis D. N., Goldstraw P., Nicholson A. G., Brasseur F., Looijenga L., Weber B. L., Chiew Y.-E., De Fazio A., Greaves M. F., Green A. R., Campbell P., Birney E., Easton D. F., Chenevix-Trench G., Tan M.-H., Khoo S. K., Teh B. T., Yuen S. T., Leung S. Y., Wooster R., Futreal P. A., Stratton M. R. 2007. Patterns of somatic mutation in human cancer genomes. Nature 446:153-158.
96. Greenman C., Wooster R., Futreal P. A., Stratton M. R., Easton D. F. 2006. Statistical analysis of pathogenicity of somatic mutations in cancer. Genetics 173:2187-2198.
97. Greenman C. D., Bignell G., Butler A., Edkins S., Hinton J., Beare D., Swamy S., Santarius T., Chen L., Widaa S., Futreal P. A., Stratton M. R. 2010. PICNIC: an algorithm to predict absolute allelic copy number variation with microarray cancer data. Biostatistics 11:164-175.
98. Greenman C. D., Pleasance E. D., Newman S., Yang F., Fu B., Nik-Zainal S., Jones D., Lau K. W., Carter N., Edwards P. A. W., Futreal P. A., Stratton M. R., Campbell P. J. 2012. Estimation of rearrangement phylogeny for cancer genomes. Genome. Res. 22:346-361.
99. Guenthoer J., Diede S. J., Tanaka H., Chai X., Hsu L., Tapscott S. J., Porter P. L. 2012. Assessment of palindromes as platforms for DNA amplification in breast cancer. Genome. Res. 22:232-245.
100. Ha G., Roth A., Khattra J., Ho J., Yap D., Prentice L. M., Melnyk N., McPherson A., Bashashati A., Laks E., Biele J., Ding J., Le A., Rosner J., Shumansky K., Marra M. A., Gilks C. B., Huntsman D. G., McAlpine J. N., Aparicio S., Shah S. P. 2014. Titan: Inference of copy number architectures in clonal cell populations from tumor whole genome sequence data. Genome Res.
101. Haccou P., Jagers P., Vatutin V. A., eds. 2005. Branching processes: Variation, growth, and extinction of populations. Cambridge (UK): Cambridge University Press.
102. Haeno H., Iwasa Y., Michor F. 2007. The evolution of two mutations during clonal expansion. Genetics 177:2209-2221.
103. Hanahan D., Weinberg R. A. 2000. The hallmarks of cancer. Cell. 100:57-70.
104. Hanahan D., Weinberg R. A. 2011. Hallmarks of cancer: the next generation. Cell. 144:646-674.
105. Hastings P. J., Lupski J. R., Rosenberg S. M., Ira G. 2009. Mechanisms of change in gene copy number. Nat. Rev. Genet. 10:551-564.
106. Hidalgo M., Amant F., Biankin A. V., Budinsk E., Byrne A. T., Caldas C., Clarke R. B. De Jong S., Jonkers J., Mlandsmo G. M., Roman-Roman S., Seoane J., Trusolino L., Villanueva A. 2014. Patient-derivedxenograft models: An emerging platform for translational cancer research. Cancer Discov. 4:998-1013.
107. Hjelm M., Höglund M., Lagergren J. 2006. New probabilistic network models and algorithms for oncogenesis. J. Comput. Biol. 13:853-865.
108. Hochberg M. E., Thomas F., Assenat E., Hibner U. 2013. Preventive evolutionary medicine of cancers. Evol. Appl. 6:134-143.
109. Höglund M., Gisselsson D., Mandahl N., Johansson B., Mertens F., Mitelman F., Säll T. 2001. Multivariate analyses of genomic imbalances in solid tumors reveal distinct and converging pathways of karyotypic evolution. Genes Chromosomes Cancer 31:156-171.
110. Hong Y. J., Marjoram P., Shibata D., Siegmund K. D. 2010. Using DNA methylation patterns to infer tumor ancestry. PLoS ONE 5:e12002.
111. Hou Y., Song L., Zhu P., Zhang B., Tao Y., Xu X., Li F., Wu K., Liang J., Shao D., Wu H., Ye X., Ye C., Wu R., Jian M., Chen Y., Xie W., Zhang R., Chen L., Liu X., Yao X., Zheng H., Yu C., Li Q., Gong Z., Mao M., Yang X., Yang L., Li J., Wang W., Lu Z., Gu N., Laurie G., Bolund L., Kristiansen K., Wang J., Yang H., Li Y., Zhang X., Wang J. 2012. Single-cell exome sequencing and monoclonal evolution of a JAK2-negative myeloproliferative neoplasm. Cell 148:873-885.
112. Iwasa Y., Michor F., Nowak M. A. 2003. Evolutionary dynamics of escape from biomedical intervention. Proc. Biol. Sci. 270:2573-2578.
113. Iwasa Y., Michor F., Nowak M. A. 2004. Evolutionary dynamics of invasion and escape. J. Theor. Biol. 226:205-214.
114. Iwasa Y., Nowak M. A., Michor F. 2006. Evolution of resistance during clonal expansion. Genetics 172:2557-2566.
115. Jeon J., Meza R., Moolgavkar S. H., Luebeck E. G. 2008. Evaluation of screening strategies for pre-malignant lesions using a biomathematical approach. Math. Biosci. 213:56-70.
116. Jiang F., Desper R., Papadimitriou C. H., Schffer A. A., Kallioniemi O. P., Richter J., Schraml P., Sauter G., Mihatsch M. J., Moch H. 2000. Construction of evolutionary tree models for renal cell carcinoma from comparative genomic hybridization data. Cancer Res. 60:6503-6509.
117. Jiao W., Vembu S., Deshwar A. G., Stein L., Morris Q. 2014. Inferring clonal evolution of tumors from single nucleotide somatic mutations. BMC Bioinformatics 15:35.
118. Johnston M. D., Edwards C. M., Bodmer W. F., Maini P. K., Chapman S. J. 2007. Mathematical modeling of cell population dynamics in the colonic crypt and in colorectal cancer. Proc. Natl. Acad. Sci. USA 104:4008-4013.
119. Junttila M. R., De Sauvage F. J. 2013. Influence of tumour microenvironment heterogeneity on therapeutic response. Nature 501:346-354.
120. Karp R. 1971. A simple derivation of Edmonds' algorithm for optimum branching. Networks 1:265-272.
121. Khalique L., Ayhan A., Whittaker J. C., Singh N., Jacobs I. J., Gayther S. A., Ramus S. J. 2009. The clonal evolution of metastases from primary serous epithelial ovarian cancers. Int. J. Cancer 124:1579-1586.
122. Kim K. I., Simon R. 2014. Using single cell sequencing data to model the evolutionary history of a tumor. BMC Bioinformatics 15:27.
123. Kimmel M., Axelrod D. E. 2002. Branching processes in biology. New York (NY): Springer.
124. Kimura M. 1983. The neutraltheoryofmolecular evolution. Cambridge (UK): Cambridge University Press.
125. Kingman J. 1982. The coalescent. Stoch. Proc. Appl. 13:235-248.
126. Klein C. A. 2013. Selection and adaptation during metastatic cancer progression. Nature 501:365-372.
127. Knudson A. G. J. 1971. Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA 68:820-823.
128. Koboldt D. C., Zhang Q., Larson D. E., Shen D., McLellan M. D., Lin L., Miller C. A., Mardis E. R., Ding L., Wilson R. K. 2012. Varscan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 22:568-576.
129. Kolmogorov A. N. 1931. Über die analytischen Methoden in der Wahrscheinlichkeitsrechnung. Math. Annalen. 104:415-458.
130. Komarova N. L. 2006. Spatial stochastic models for cancer initiation and progression. Bull. Math. Biol. 68:1573-1599.
131. Komarova N. L. 2007. Loss- and gain-of-function mutations in cancer: mass-action, spatial and hierarchical models. J. Statist. Phys. 128:413-446.
132. Korbel J. O., Campbell P. J. 2013. Criteria for inference of chromothripsis in cancer genomes. Cell 152:1226-1236.
133. Kreso A., Dick J. E. 2014. Evolution of the cancer stem cell model. Cell Stem Cell 14:3.
134. Kumar P., Henikoff S., Ng P. C. 2009. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat. Protoc. 4:1073-1081.
135. Kunkel T. A., Bebenek K. 2000. DNA replication fidelity. Annu. Rev. Biochem. 69:497-529.
136. Lambert G., Estvez-Salmeron L., Oh S., Liao D., Emerson B. M., Tlsty T. D., Austin R. H. 2011. An analogy between the evolution of drug resistance in bacterial communities and malignant tissues. Nat. Rev. Cancer 11:375-382.
137. Landau D. A., Carter S. L., Stojanov P., McKenna A., Stevenson K., Lawrence M. S., Sougnez C., Stewart C., Sivachenko A., Wang L., Wan Y., Zhang W., Shukla S. A., Vartanov A., Fernandes S. M., Saksena G., Cibulskis K., Tesar B., Gabriel S., Hacohen N., Meyerson M., Lander E. S., Neuberg D., Brown J. R., Getz G., Wu C. J. 2013. Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell 152:714-726.
138. Landry J. J. M., Pyl P. T., Rausch T., Zichner T., Tekkedil M. M., Sttz A. M., Jauch A., Aiyar R. S., Pau G., Delhomme N., Gagneur J., Korbel J. O., Huber W., Steinmetz L. M. 2013. The genomic and transcriptomic landscape of a HeLa cell line. G3 (Bethesda) 3:1213-1224.
139. Larson N. B., Fridley B. L. 2013. Purbayes: estimating tumor cellularity and subclonality in next-generation sequencing data. Bioinformatics 29:1888-1889.
140. Lawrence M. S., Stojanov P., Mermel C. H., Robinson J. T., Garraway L. A., Golub T. R., Meyerson M., Gabriel S. B., Lander E. S., Getz G. 2014. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature. 505:495-501.
141. Lawrence M. S., Stojanov P., Polak P., Kryukov G. V., Cibulskis K., Sivachenko A., Carter S. L., Stewart C., Mermel C. H., Roberts S. A., Kiezun A., Hammerman P. S., McKenna A., Drier Y., Zou L., Ramos A. H., Pugh T. J., Stransky N., Helman E., Kim J., Sougnez C., Ambrogio L., Nickerson E., Shefler E., Cortes M. L., Auclair D., Saksena G., Voet D., Noble M., Di Cara D., Lin P., Lichtenstein L., Heiman D. I., Fennell T., Imielinski M., Hernandez B., Hodis E., Baca S., Dulak A. M., Lohr J., Landau D.-A., Wu C. J., Melendez-Zajgla J., Hidalgo-Miranda A., Koren A., McCarroll S. A., Mora J., Lee R. S., Crompton B., Onofrio R., Parkin M., Winckler W., Ardlie K., Gabriel S. B., Roberts C. W. M., Biegel J. A., Stegmaier K., Bass A. J., Garraway L. A., Meyerson M., Golub T. R., Gordenin D. A., Sunyaev S., Lander E. S., Getz G. 2013. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499:214-218.
142. Letouzé E., Allory Y., Bollet M. A., Radvanyi F., Guyon F. 2010. Analysis of the copy number profilesofseveral tumor samples from the same patient reveals the successive steps in tumorigenesis. Genome Biol. 11:R76.
143. Loeb L. A. 2001. A mutator phenotype in cancer. Cancer Res. 61:3230-3239.
144. Loeb L. A. 2011. Human cancers express mutator phenotypes: origin, consequences and targeting. Nat. Rev. Cancer 11:450-457.
145. Luebeck E. G., Curtius K., Jeon J., Hazelton W. D. 2013. Impact of tumor progression on cancer incidence curves. Cancer Res. 73:1086-1096.
146. Luebeck E. G., Moolgavkar S. H. 2002. Multistage carcinogenesis and the incidence of colorectal cancer. Proc. Natl. Acad. Sci. USA 99:15095-15100.
147. Luria S. E., Delbrück M. 1943. Mutations of bacteria from virus sensitivity to virus resistance. Genetics 28:491-511.
148. Maley C. C., Galipeau P. C., Finley J. C., Wongsurawat V. J., Li X., Sanchez C. A., Paulson T. G., Blount P. L., Risques R.-A., Rabinovitch P. S., Reid B. J. 2006. Geneticclonal diversitypredicts progressionto esophageal adenocarcinoma. Nat. Genet. 38:468-473.
149. Marjoram P., Molitor J., Plagnol V., Tavaré S. 2003. Markov chain Monte Carlo without likelihoods. Proc. Natl. Acad. Sci. USA 100:15324-15328.
150. Marusyk A., Almendro V., Polyak K. 2012. Intra-tumour heterogeneity: a looking glass for cancer? Nat. Rev. Cancer 12:323-334.
151. Maynard Smith J. 1982. Evolution and the theoryofgames. Cambridge (UK): Cambridge University Press.
152. McFarland C. D., Korolev K. S., Kryukov G. V., Sunyaev S. R., Mirny L. A. 2013. Impact of deleterious passenger mutations on cancer progression. Proc. Natl. Acad. Sci. USA 110:2910-2915.
153. Meacham C. E., Morrison S. J. 2013. Tumour heterogeneity and cancer cell plasticity. Nature 501:328-337.
154. Merlo L. M. F., Pepper J. W., Reid B. J., Maley C. C. 2006. Cancer as an evolutionary and ecological process. Nat. Rev. Cancer 6:924-935.
155. Meza R., Jeon J., Moolgavkar S. H., Luebeck E. G. 2008. Age-specific incidence of cancer: Phases, transitions, and biological implications. Proc. Natl. Acad. Sci. USA 105:16284-16289.
156. Michor F., Hughes T. P., Iwasa Y., Branford S., Shah N. P., Sawyers C. L., Nowak M. A. 2005. Dynamics of chronic myeloid leukaemia. Nature 435:1267-1270.
157. Michor F., Iwasa Y., Nowak M. A. 2004. Dynamics of cancer progression. Nat. Rev. Cancer 4:197-205.
158. Michor F., Polyak K. 2010. The origins and implications of intratumor heterogeneity. Cancer Prev. Res. (Phila) 3:1361-1364.
159. Miller C. A., White B. S., Dees N. D., Griffith M., Welch J. S., Griffith O. L., Vij R., Tomasson M. H., Graubert T. A., Walter M. J., Ellis M. J., Schierding W., Di Persio J. F., Ley T. J., Mardis E. R., Wilson R. K., Ding L. 2014. Sciclone: Inferring clonal architecture and tracking thespatial and temporal patternsoftumor evolution. PLoS Comput. Biol. 10:e1003665.
160. Moran P. A. P. 1958. Random processes in genetics. Math. Proc. Cambridge. 54:60-71.
161. Murray J. D. 2002. Mathematical biology, Vol. 2. 3rd ed. New York (NY): Springer.
162. Murtaza M., Dawson S.-J., Tsui D. W. Y., Gale D., Forshew T., Piskorz A. M., Parkinson C., Chin S.-F., Kingsbury Z., Wong A. S. C., Marass F., Humphray S., Hadfield J., Bentley D., Chin T. M., Brenton J. D., Caldas C., Rosenfeld N. 2013. Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA. Nature 497:108-112.
163. Navin N., Kendall J., Troge J., Andrews P., Rodgers L., McIndoo J., Cook K., Stepansky A., Levy D., Esposito D., Muthuswamy L., Krasnitz A., McCombie W. R., Hicks J., Wigler M. 2011. Tumour evolution inferred by single-cell sequencing. Nature 472:90-94.
164. Navin N., Krasnitz A., Rodgers L., Cook K., Meth J., Kendall J., Riggs M., Eberling Y., Troge J., Grubor V., Levy D., Lundin P., Mnr S., Zetterberg A., Hicks J., Wigler M. 2010. Inferring tumor progression from genomic heterogeneity. Genome Res. 20:68-80.
165. Navin N. E., Hicks J. 2010. Tracing the tumor lineage. Mol. Oncol. 4:267-283.
166. Nazarian R., Shi H., Wang Q., Kong X., Koya R. C., Lee H., Chen Z., Lee M.-K., Attar N., Sazegar H., Chodon T., Nelson S. F., McArthur G., Sosman J. A., Ribas A., Lo R. S. 2010. Melanomas acquire resistance to B-RAF (V600E) inhibition by RTK or N-RAS upregulation. Nature 468:973-977.
167. Neuhauser C., Krone S. M. 1997. The genealogy of samples in models with selection. Genetics 145:519-534.
168. Nicolas P., Kim K. M., Shibata D., Tavar S. 2007. The stem cell population of the human colon crypt: analysis via methylation patterns. PLoS Comput. Biol. 3:e28.
169. Nik-Zainal S., Alexandrov L. B., Wedge D. C., Van Loo P., Greenman C. D., Raine K., Jones D., Hinton J., Marshall J., Stebbings L. A., Menzies A., Martin S., Leung K., Chen L., Leroy C., Ramakrishna M., Rance R., Lau K. W., Mudie L. J., Varela I., McBride D. J., Bignell G. R., Cooke S. L., Shlien A., Gamble J., Whitmore I., Maddison M., Tarpey P. S., Davies H. R., Papaemmanuil E., Stephens P. J., McLaren S., Butler A. P., Teague J. W., Jönsson G., Garber J. E., Silver D., Miron P., Fatima A., Boyault S., Langerod A., Tutt A., Martens J. W. M., Aparicio S. A. J. R., Borg A., Salomon A. V., Thomas G., Borresen-Dale A.-L., Richardson A. L., Neuberger M. S., Futreal P. A., Campbell P. J., Stratton M. R., Breast Cancer Working Group of the International Cancer Genome Consortium. 2012a. Mutational processes molding the genomes of 21 breast cancers. Cell. 149:979-993.
170. Nik-Zainal S., Van Loo P., Wedge D. C., Alexandrov L. B., Greenman C. D., Lau K. W., Raine K., Jones D., Marshall J., Ramakrishna M., Shlien A., Cooke S. L., Hinton J., Menzies A., Stebbings L. A., Leroy C., Jia M., Rance R., Mudie L. J., Gamble S. J., Stephens P. J., McLaren S., Tarpey P. S., Papaemmanuil E., Davies H. R., Varela I., McBride D. J., Bignell G. R., Leung K., Butler A. P., Teague J. W., Martin S., Jönsson G., Mariani O., Boyault S., Miron P., Fatima A., Langerod A., Aparicio S. A. J. R., Tutt A., Sieuwerts A. M., Borg A., Thomas G., Salomon A. V., Richardson A. L., Borresen-Dale A.-L., Futreal P. A., Stratton M. R., Campbell P. J., Breast Cancer Working Groupof the International Cancer Genome Consortium. 2012b. The life history of 21 breast cancers. Cell 149:994-1007.
171. Nolan-Stevaux O., Tedesco D., Ragan S., Makhanov M., Chenchik A., Ruefli-Brasse A., Quon K., Kassner P. D. 2013. Measurement of cancer cell growth heterogeneity through lentiviral barcoding identifies clonal dominance as a characteristic of in vivo tumor engraftment. PLoS ONE 8:e67316.
172. Nordling CO. 1953. A new theory on cancer-inducing mechanism. Br. J. Cancer 7:68-72.
173. Norquist B., Wurz K. A., Pennil C. C., Garcia R., Gross J., Sakai W., Karlan B. Y., Taniguchi T., Swisher E. M. 2011. Secondary somatic mutations restoring BRCA1/2 predict chemotherapy resistance in hereditary ovarian carcinomas. J. Clin. Oncol. 29:3008-3015.
174. Nowak M. A. 2006a. Evolutionarydynamics: exploringtheequations of life. Cambridge (MA): Belknap Press of Harvard University Press.
175. Nowak M. A. 2006b. Five rules for the evolution of cooperation. Science 314:1560-1563.
176. Nowak M. A., Michor F., Iwasa Y. 2003. The linear process of somatic evolution. Proc. Natl. Acad. Sci. USA 100:14966-14969.
177. Nowell P. C. 1976. The clonal evolution of tumor cell populations. Science 194:23-28.
178. Oesper L., Mahmoody A., Raphael B. 2013. Theta: Inferring intratumor heterogeneity from high-throughput DNA sequencing data. Genome Biol. 14:R80.
179. Orr H. A. 2005. The probability of parallel evolution. Evolution: Int. J. Org. Evolut. 59:216-220.
180. Otto S. P., Whitlock M. C. 2001. Fixation probabilities and times, John Wiley & Sons, Ltd.
181. Owen M. R., Alarcón T., Maini P. K., Byrne H. M. 2009. Angiogenesis and vascular remodelling in normal and cancerous tissues. J. Math. Biol. 58:689-721.
182. Papaemmanuil E., Gerstung M., Malcovati L., Tauro S., Gundem G., Van Loo P., Yoon C. J., Ellis P., Wedge D. C., Pellagatti A., Shlien A., Groves M. J., Forbes S. A., Raine K., Hinton J., Mudie L. J., McLaren S., Hardy C., Latimer C., Della Porta M. G., O'Meara S., Ambaglio I., Galli A., Butler A. P., Walldin G., Teague J. W. Quek L., Sternberg A., Gambacorti-Passerini C., Cross N. C. P. Green A. R., Boultwood J., Vyas P., Hellstrom-Lindberg E., Bowen D., Cazzola M., Stratton M. R., Campbell P. J., Chronic Myeloid Disorders working group of the International Cancer Genome Consortium. 2013. Clinical and biological implications of driver mutations in myelodysplastic syndromes. Blood 122:3616-3627.
183. Park S. C., Simon D., Krug J. 2010. The speed of evolution in large asexual populations. J. Stat. Phys. 138:381-410.
184. Perfahl Ho., Byrne H. M., Chen T., Estrella V., Alarcon T., Lapin A., Gatenby R. A., Gillies R. J., Lloyd M. C., Maini P. K., Reuss M., Owen M. R. 2011. Multiscale modelling of vascular tumour growth in 3D: the roles of domain size and boundary conditions. PLoS ONE 6:e14790.
185. Pharoah P. D. P., Dunning A. M., Ponder B. A. J., Easton D. F. 2004. Association studies for finding cancer-susceptibility genetic variants. Nat. Rev. Cancer 4:850-860.
186. Podlaha O., Riester M., De S., Michor F. 2012. Evolution of the cancer genome. Trends Genet. 28:155-163.
187. Poste G., Doll J., Fidler I. J. 1981. Interactions among clonal subpopulations affect stability of the metastatic phenotype in polyclonal populations of B16 melanoma cells. Proc. Natl. Acad. Sci. USA 78:6226-6230.
188. Potter N. E., Ermini L., Papaemmanuil E., Cazzaniga G., Vijayaraghavan G., Titley I., Ford A., Campbell P., Kearney L., Greaves M. 2013. Single-cell mutational profiling and clonal phylogeny in cancer. Genome Res. 23:2115-2125.
189. Purdom E., Ho C., Grasso C. S., Quist M. J., Cho R. J., Spellman P. 2013. Methodsandchallenges in timing chromosomal abnormalities within cancer samples. Bioinformatics 29:3113-3120.
190. Radmacher M. D., Simon R., Desper R., Taetle R., Schäffer A. A., Nelson M. A. 2001. Graph models of oncogenesis with an application to melanoma. J. Theor. Biol. 212:535-548.
191. Rahnenführer J., Beerenwinkel N., Schulz W. A., Hartmann C., Von Deimling A., Wullich B., Lengauer T. 2005. Estimating cancer survival and clinical outcome based on genetic tumor progression scores. Bioinformatics 21:2438-2446.
192. Roose T., Chapman S., Maini P. 2007. Mathematical models of avascular tumor growth. SIAM Review 49:179-208.
193. Rosenberg N. A., Nordborg M. 2002. Genealogical trees, coalescent theory and the analysis of genetic polymorphisms. Nat. Rev. Genet. 3:380-390.
194. Roth A., Khattra J., Yap D., Wan A., Justina Biele E. L., Ha G., Aparicio S., Bouchard-Cote A., Shah S. P. 2014. Pyclone: statistical inference of clonal population structure in cancer. Nature Methods. Published online 16 March 2014.
195. Saitou N., Nei M. 1987. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4:406-425.
196. Sakoparnig T., Beerenwinkel N. 2012. Efficient sampling for Bayesianinferenceof conjunctive Bayesian networks. Bioinformatics 28:2318-2324.
197. Salk J. J., Fox E. J., Loeb L. A. 2010. Mutational heterogeneity in human cancers: origin and consequences. Annu. Rev. Pathol. 5:51-75.
198. Schöllnberger H., Beerenwinkel N., Hoogenveen R., Vineis P. 2010. Cell selection as driving force in lung and colon carcinogenesis. Cancer Res. 70:6797-6803.
199. Schuster P., Sigmund K. 1983. Replicator dynamics. J. Theor. Biol. 100:533-538.
200. Schwarz R. F., Fletcher W., Förster F., Merget B., Wolf M., Schultz J., Markowetz F. 2010. Evolutionary distances in the twilight zone-a rational kernel approach. PLoS ONE 5:e15788.
201. Schwarz R. F., Ng C. K., Coooke S. L., Newman S., Temple J., Piskorz A. M., Gale D., Sayal K., Murtaza M., Baldwin P. J., Rosenfeld N., Earl H. M., Sala E., Jimenez-Linan M., Parkinson C. A., Markowetz F., Brenton J. D. 2014a. Phylogenetic quantification of intra-tumor heterogeneity predicts time to relapse in high-grade serous ovarian cancer. PLoS Medicine (in revision).
202. Schwarz R. F., Trinh A., Sipos B., Brenton J. D., Goldman N., Markowetz F. 2014b. Phylogenetic quantification of intra-tumour heterogeneity. PLoS Comput. Biol. 10:e1003535.
203. Shah S. P., Roth A., Goya R., Oloumi A., Ha G., Zhao Y., Turashvili G., Ding J., Tse K., Haffari G., Bashashati A., Prentice L. M., Khattra J., Burleigh A., Yap D., Bernard V., McPherson A., Shumansky K., Crisan A., Giuliany R., Heravi-Moussavi A., Rosner J., Lai D., Birol I., Varhol R., Tam A., Dhalla N., Zeng T., Ma K., Chan S. K., Griffith M., Moradian A., Cheng S.-W. G., Morin G. B., Watson P., Gelmon K., Chia S., Chin S.-F., Curtis C., Rueda O. M., Pharoah P. D., Damaraju S., Mackey J., Hoon K., Harkins T., Tadigotla V., Sigaroudinia M., Gascard P., Tlsty T., Costello J. F., Meyer I. M., Eaves C. J., Wasserman W. W., Jones S., Huntsman D., Hirst M., Caldas C., Marra M. A., Aparicio S. 2012. The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature 486:395-399.
204. Shahrabi Farahani H., Lagergren J. 2013. Learning oncogenetic networks by reducing to MILP. PLoS ONE 8:e65773.
205. Shapiro E., Biezuner T., Linnarsson S. 2013. Single-cell sequencingbased technologies will revolutionize whole-organism science. Nat. Rev. Genet. 14:618-630.
206. Shen M. M. 2013. Chromoplexy: a new category of complex rearrangements in the cancer genome. Cancer Cell 23:567-569.
207. Solé R. V., Deisboeck T. S. 2004. An error catastrophe in cancer? J. Theor. Biol. 228:47-54.
208. Sottoriva A., Spiteri I., Piccirillo S. G. M., Touloumis A., Collins V. P., Marioni J. C., Curtis C., Watts C., Tavar S. 2013a. Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc. Natl. Acad. Sci. USA 110:4009-4014.
209. Sottoriva A., Spiteri I., Shibata D., Curtis C., Tavar S. 2013b. Singlemolecule genomic data delineate patient-specific tumor profiles and cancer stem cell organization. Cancer Res. 73:41-49.
210. Sprouffske K., Pepper J. W., Maley C. C. 2011. Accurate reconstruction of the temporal order of mutations in neoplastic progression. Cancer Prev. Res. (Phila) 4:1135-1144.
211. Stadler P. F. 1991. Dynamics of autocatalytic reaction networks. IV: Inhomogeneous replicator networks. Biosystems 26:1-19.
212. Stephens P. J., Greenman C. D., Fu B., Yang F., Bignell G. R., Mudie L. J., Pleasance E. D., Lau K. W., Beare D., Stebbings L. A., McLaren S., Lin M.-L., McBride D. J., Varela I., Nik-Zainal S., Leroy C., Jia M., Menzies A., Butler A. P., Teague J. W., Quail M. A., Burton J., Swerdlow H., Carter N. P., Morsberger L. A., Iacobuzio-Donahue C., Follows G. A., Green A. R., Flanagan A. M., Stratton M. R., Futreal P. A., Campbell P. J. 2011. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell. 144:27-40.
213. Stratton M. R., Campbell P. J., Futreal P. A. 2009. The cancer genome. Nature 458:719-724.
214. Strino F., Parisi F., Micsinai M., Kluger Y. 2013. Trap: a tree approach for fingerprinting subclonal tumor composition. Nucleic Acids Res. 41:e165
215. Szabo A., Boucher K. 2002. Estimating an oncogenetic tree when false negatives and positives are present. Math. Biosci. 176:219-236.
216. Taylor C., Fudenberg D., Sasaki A., Nowak M. A. 2004. Evolutionary game dynamics in finite populations. Bull. Math. Biol. 66:1621-1644.
217. Thalhauser C. J., Lowengrub J. S., Stupack D., Komarova N. L. 2010. Selection in spatial stochastic models of cancer: migration as a key modulator of fitness. Biol. Direct. 5:21.
218. Tofigh A., Sjölund E., Höglund M., Lagergren J. 2011. A global structural EM algorithm for a model of cancer progression. In: Shawe-Taylor J., Zemel R., Bartlett P., Pereira F., Weinberger K., editors. Advances in neural information processing systems 24. pp. 163-171. Red Hook (NY): Curran Associates, Inc.
219. Tomasetti C., Vogelstein B., Parmigiani G. 2013. Half or more of the somatic mutations in cancers of self-renewing tissues originate prior to tumor initiation. Proc. Natl. Acad. Sci. USA 110:1999-2004.
220. Tomlinson I. P. 1997. Game-theory models of interactions between tumour cells. Eur. J. Cancer 33:1495-1500.
221. Trinh A., Rye I. H., Almendro V., Helland A., Russnes H. G., Markowetz F. 2014. Goifish: a system for the quantification of single cell heterogeneity from ifish images. Genome Biol. 15:442.
222. Van Loo P., Nordgard S. H., Lingjærde O. C., Russnes H. G., Rye I. H., Sun W., Weigman V. J., Marynen P., Zetterberg A., Naume B., Perou C. M., Børresen-Dale A.-L., Kristensen V. N. 2010. Allele-specific copy number analysis of tumors. Proc. Natl. Acad. Sci. USA 107:16910-16915.
223. Vogelstein B., Papadopoulos N., Velculescu V. E., Zhou S., Diaz L. A. Jr, Kinzler K. W. 2013. Cancer genome landscapes. Science 339:1546-1558.
224. Von Heydebreck A., Gunawan B., Fuzesi L. 2004. Maximum likelihood estimation of oncogenetic tree models. Biostatistics 5:545-556.
225. Weinberg R. A. 2013. The Biology of Cancer. 2nd ed. New York (NY): Garland Science.
226. Weinreich D. M., Delaney N. F., Depristo M. A., Hartl D. L. 2006. Darwinian evolution can follow only very few mutational paths to fitter proteins. Science 312:111-114.
227. Werner B., Dingli D., Traulsen A. 2013. A deterministic model for the occurrence and dynamics of multiple mutations in hierarchically organized tissues. J. R. Soc. Interface 10:20130349.
228. Wilm A., Aw P. P. K., Bertrand D., Yeo G. H. T., Ong S. H., Wong C. H., Khor C. C., Petric R., Hibberd M. L., Nagarajan N. 2012. Lofreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets. Nucleic Acids Res. 40:11189-11201.
229. Wright S. 1931. Evolution in Mendelian populations. Genetics 16:97-159.
230. Wright S. 1945. The differential equation of the distribution of gene frequencies. Proc. Natl. Acad. Sci. USA 31:382-389.
231. Xu X., Hou Y., Yin X., Bao L., Tang A., Song L., Li F., Tsang S., Wu K., Wu H., He W., Zeng L., Xing M., Wu R., Jiang H., Liu X., Cao D., Guo G., Hu X., Gui Y., Li Z., Xie W., Sun X., Shi M., Cai Z., Wang B., Zhong M., Li J., Lu Z., Gu N., Zhang X., Goodman L., Bolund L., Wang J., Yang H., Kristiansen K., Dean M., Li Y., Wang J. 2012. Single-cell exome sequencing reveals single-nucleotide mutation characteristics of a kidney tumor. Cell 148:886-895.
232. Youn A., Simon R. 2012. Estimating the order of mutations during tumorigenesis from tumor genome sequencing data. Bioinformatics 28:1555-1561.
233. Yuan Y., Failmezger H., Rueda O. M., Ali H. R., Gräf S., Chin S.-F., Schwarz R. F., Curtis C., Dunning M. J., Bardwell H., Johnson N., Doyle S., Turashvili G., Provenzano E., Aparicio S., Caldas C., Markowetz F. 2012. Quantitative image analysis of cellular heterogeneity in breast tumors complements genomic profiling. Sci. Transl. Med. 4:157ra143.
234. Zare H., Wang J., Hu A., Weber K., Smith J., Nickerson D., Song C., Witten D., Blau C. A., Noble W. S. 2014. Inferring clonal composition from multiple sections of a breast cancer. PLoS Comput. Biol. 10:e1003703.
235. Zhao R., Michor F. 2013. Patterns of proliferative activity in the colonic crypt determine crypt stability and rates of somatic evolution. PLoS Comput. Biol. 9:e1003082.